A new healthcare invention from the University of Tennessee Health Science Center’s (UTHSC) Center for Healthcare Improvement and Patient Simulation (CHIPS) in Memphis is a true testament to scientific collaboration and the power of the University of Tennessee ecosystem. In April 2019, a team of researchers and practitioners debuted an Infant Pericardiocentesis Trainer at the (read more)
Memphis Office
Promising New Treatment for Prostate Cancer Also Demonstrates Encouraging Results Against Triple Negative Breast Cancer
Efficacy Preclinical Studies Conducted by UTRF, UTHSC, and Veru Inc.’s University-Industry Partnership Memphis, Tennessee: A research collaboration between the University of Tennessee Health Science Center (UTHSC), the University of Tennessee Research Foundation (UTRF), and biopharmaceutical company Veru Inc. has resulted in a promising next generation oral cancer therapy, VERU-111, which has the potential to treat (read more)
Following the Molecules: From Drug Discovery to Entrepreneurship
A new startup born at the University of Tennessee Health Science Center (UTHSC) in Memphis aims to reshape treatment for pediatric leukemia and neuroblastoma. SEAK Therapeutics, LLC, began in the research lab of Pharmaceutical Sciences Professor Wei Li, who also serves as the Director of the UT College of Pharmacy Drug Discovery Center. In 2017, (read more)